Outcome of Board Meeting held on 19.05.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
Gayatri BioOrganics Ltd reported zero revenue from operations for FY2026 (same as FY2025), with net loss worsening from ₹72.65 lakhs to ₹111.18 lakhs. The company has negative other equity of ₹11,579.31 lakhs indicating severe capital erosion. Total assets stand at ₹171.75 lakhs against borrowings of ₹592.58 lakhs (₹352.14 lakhs non-current + ₹240.44 lakhs current). Operating cash outflows increased to ₹73.54 lakhs from ₹55.06 lakhs. The Board approved the audited financial results and appointed M/s. Vas & Co. as internal auditors for FY2026-27. The company disclosed contingent liabilities including customs duty disputes of ₹271.73 lakhs and excise duty disputes of ₹1,146.91 lakhs. The auditors issued an unmodified opinion but included Emphasis of Matters regarding undisclosed notes 2.8, 2.9(a), and 2.11.
The company is effectively a shell with zero revenue and mounting losses, negative equity, and heavy reliance on promoter support as disclosed in the going concern note. Shareholders face extreme risk as the company has lost its entire net worth and continues burning cash with no operating income.